Liver Arginase anticorps
-
- Antigène Voir toutes Liver Arginase (ARG1) Anticorps
- Liver Arginase (ARG1) (Arginase, Liver (ARG1))
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Liver Arginase est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF), Immunoprecipitation (IP), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Réactivité croisée
- Humain, Souris, Rat
- Attributs du produit
-
Rabbit Polyclonal antibody to Arginase 1 (arginase, liver)
Arginase 1 antibody - Purification
- Purified by antigen-affinity chromatography.
- Classe de qualité
- KO Validated
- Immunogène
- Full length human Arginase 1 Recombinant protein.
- Isotype
- IgG
-
-
- Indications d'application
- WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IHC-Fr: 1:100-1:1000. FACS: 1:50-1:200. IP: 1:100-1:1000. ELISA: 1:1000-1:10000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Commentaires
-
Positive Control: HepG2
Validation: KO/KD, Orthogonal
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.26 mg/mL
- Buffer
- 1XPBS pH 7, 1 % BSA, 20 % Glycerol, 0.025 % ProClin 300
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
Sindbis Virus with Anti-OX40 Overcomes the Immunosuppressive Tumor Microenvironment of Low-Immunogenic Tumors." dans: Molecular therapy oncolytics, Vol. 17, pp. 431-447, (2020) (PubMed).
: "Optimizing Mannose "Click" Conjugation to Polymeric Nanoparticles for Targeted siRNA Delivery to Human and Murine Macrophages." dans: ACS omega, Vol. 4, Issue 16, pp. 16756-16767, (2019) (PubMed).
: "Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice." dans: Nature medicine, Vol. 24, Issue 9, pp. 1418-1429, (2019) (PubMed).
: "Metabolic regulation of gene expression by histone lactylation." dans: Nature, Vol. 574, Issue 7779, pp. 575-580, (2019) (PubMed).
: "IRAK-M alters the polarity of macrophages to facilitate the survival of Mycobacterium tuberculosis." dans: BMC microbiology, Vol. 17, Issue 1, pp. 185, (2018) (PubMed).
: "Identification of different macrophage subpopulations with distinct activities in a mouse model of oxygen-induced retinopathy." dans: International journal of molecular medicine, Vol. 40, Issue 2, pp. 281-292, (2018) (PubMed).
: "Roles of programmed death protein 1/programmed death-ligand 1 in secondary brain injury after intracerebral hemorrhage in rats: selective modulation of microglia polarization to anti-inflammatory ..." dans: Journal of neuroinflammation, Vol. 14, Issue 1, pp. 36, (2018) (PubMed).
: "The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma." dans: Oncotarget, Vol. 7, Issue 41, pp. 67333-67346, (2018) (PubMed).
: "Metabolic origins of spatial organization in the tumor microenvironment." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Issue 11, pp. 2934-2939, (2017) (PubMed).
: "Tissue matrix arrays for high-throughput screening and systems analysis of cell function." dans: Nature methods, Vol. 12, Issue 12, pp. 1197-204, (2016) (PubMed).
: "Anti-Inflammatory Immune Skewing Is Atheroprotective: Apoe-/-Fc?RIIb-/- Mice Develop Fibrous Carotid Plaques." dans: Journal of the American Heart Association, Vol. 3, Issue 6, (2014) (PubMed).
: "
-
Sindbis Virus with Anti-OX40 Overcomes the Immunosuppressive Tumor Microenvironment of Low-Immunogenic Tumors." dans: Molecular therapy oncolytics, Vol. 17, pp. 431-447, (2020) (PubMed).
-
- Antigène
- Liver Arginase (ARG1) (Arginase, Liver (ARG1))
- Autre désignation
- arginase 1 (ARG1 Produits)
- Synonymes
- anticorps SI:zC146F4.4 (novel protein with NUDIX domain), anticorps si:ch211-146f4.3, anticorps argi1, anticorps AI, anticorps AI256583, anticorps Arg-1, anticorps PGIF, anticorps arginase 1, anticorps arginase, anticorps Arginase-1, anticorps arginase, liver, anticorps L-arginase, anticorps arg1, anticorps PGTG_16455, anticorps argi1, anticorps ARG1, anticorps Arg1
- Sujet
-
Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exist (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type I isoform encoded by this gene, is a cytosolic enzyme and expressed predominantly in the liver as a component of the urea cycle. Inherited deficiency of this enzyme results in argininemia, an autosomal recessive disorder characterized by hyperammonemia.
Cellular Localization: Cytoplasm - Poids moléculaire
- 35 kDa
- ID gène
- 383
- UniProt
- P05089
- Pathways
- Cellular Response to Molecule of Bacterial Origin
-